Mesoblast (MEOBF) Total Liabilities (2014 - 2026)

Mesoblast has disclosed Total Liabilities across 13 years of filings, most recently posting $204.7 million for Q2 2026.

• In Q2 2026, Total Liabilities rose 9.31% year-over-year to $204.7 million; the TTM figure through Jun 2026 stood at $204.7 million (up 9.31% YoY), while the FY2026 annual figure was $204.7 million, up 9.31% from the prior year.
• Total Liabilities came in at $204.7 million for Q2 2026 at Mesoblast, down from $207.6 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $207.6 million in Q4 2025 to a low of $161.6 million in Q4 2023.
• Average Total Liabilities over 5 years is $178.1 million, with a median of $168.2 million recorded in 2022.
• Year-over-year, Total Liabilities retreated 3.87% in 2023 and climbed 18.88% in 2024.
• Over 5 years, Total Liabilities stood at $168.1 million in 2022, then retreated by 3.87% to $161.6 million in 2023, then rose by 18.88% to $192.1 million in 2024, then increased by 8.11% to $207.6 million in 2025, then dropped by 1.42% to $204.7 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $204.7 million in Q2 2026, $207.6 million in Q4 2025, and $187.2 million in Q2 2025.